Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot be Removed by Surgery

Summary

This clinical trial studies radiolabeled glass beads (yttrium Y 90 glass microspheres) in treating patients with unresectable hepatocellular carcinoma. Internal radiation therapy uses radioactive material placed directly into or near a tumor to kill tumor cells. Using radiolabeled glass beads to kill tumor cells may be an effective treatment for liver cancer.

Timeline

Start

2010-10-11

Primary completion

2021-06-15

Completion

2021-06-15

Drugs

Indications